Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Feliformia; Felidae; Pantherinae; Panthera; Panthera tigris,
Latin Name:
Panthera tigris altaica
Tested tissues: Heart, Kidney, Liver, Lung, Spleen, PBMC,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0023 | 2021.04 | 10X Genomics | Heart | Normal | 16479 | Link |
Vthunter_0024 | 2021.04 | 10X Genomics | Kidney | Normal | 3483 | Link |
Vthunter_0025 | 2021.04 | 10X Genomics | Liver | Normal | 10237 | Link |
Vthunter_0026 | 2021.04 | 10X Genomics | Lung | Normal | 14159 | Link |
Vthunter_0027 | 2021.04 | 10X Genomics | Spleen | Normal | 33029 | Link |
Vthunter_0057 | 2021.04 | iDrop | PBMC | Normal | 4755 | Link |
Vthunter_100005 | 2021.05 | iDrop | PBMC | Normal | 4755 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
Hepacivirus C |
Liver-Liver sinusoidal endothelial cells : 98.66% ; Lung-Ciliated cells : 95.74% ; Liver-Cholangiocytes : 92.31% ; Heart-Epicardial cells : 90.74% ; Spleen-B cells : 89.01% ; Liver-Liver sinusoidal endothelial cells : 87.50% ; Spleen-Fibroblast cells : 83.91% ; Spleen-Neural cells : 83.70% ; Spleen-B cells : 81.88% ; Spleen-Natural killer T cells : 77.16% ; Liver-Liver sinusoidal endothelial cells : 85.27% ; Liver-Cholangiocytes : 79.49% ; Lung-ATII : 73.89% ; Lung-Ciliated cells : 65.11% ; Liver-Hepatocytes : 56.17% ; Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Lung-ATII : 98.03% ; Lung-ATI : 89.80% ; Spleen-Fibroblast cells : 72.58% ; Lung-Secretory cells : 70.88% ; Spleen-B cells : 67.58% ; |
|
Dengue virus |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; Liver-Liver sinusoidal endothelial cells : 87.50% ; Spleen-Fibroblast cells : 83.91% ; Spleen-Neural cells : 83.70% ; Spleen-B cells : 81.88% ; Spleen-Natural killer T cells : 77.16% ; Spleen-Macrophages : 72.92% ; Spleen-Monocytes : 56.40% ; Spleen-B cells : 55.47% ; Lung-Mast cells : 53.97% ; |
|
Sindbis virus |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Adeno-associated virus 9 |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Adeno-associated virus - 2 |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; Lung-Ciliated cells : 55.58% ; |
|
Adeno-associated virus - 3 |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Adeno-associated virus - 8 |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Classical swine fever virus |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Venezuelan equine encephalitis virus |
Liver-Liver sinusoidal endothelial cells : 97.77% ; Lung-Ciliated cells : 92.49% ; Heart-Epicardial cells : 90.74% ; Lung-ATII : 90.43% ; Kidney-Podocytes : 86.32% ; |
|
Echovirus E6 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E7 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E11 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E12 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E13 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E20 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E21 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E29 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Echovirus E33 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Enterovirus D68 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Coxsackievirus B1 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; Lung-ATII : 55.01% ; |
|
Coxsackievirus B3 | ||
Coxsackievirus B5 | ||
Coxsackievirus A21 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Human enterovirus 70 |
Lung-Ciliated cells : 96.75% ; Heart-Epicardial cells : 85.19% ; Lung-Secretory cells : 69.80% ; Lung-ATII : 62.07% ; Lung-Macrophages : 60.75% ; |
|
Encephalomyocarditis virus |
Spleen-B cells : 95.79% ; Spleen-Macrophages : 95.44% ; Spleen-Fibroblast cells : 94.42% ; Spleen-Natural killer T cells : 94.12% ; Spleen-Monocytes : 94.01% ; |
|
Simian rotavirus A strain RRV |
Lung-Ciliated cells : 93.31% ; Liver-Liver sinusoidal endothelial cells : 80.36% ; Lung-ATII : 76.26% ; Liver-Hepatocytes : 70.34% ; Spleen-B cells : 69.04% ; Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; Liver-Cholangiocytes : 64.10% ; Liver-Liver sinusoidal endothelial cells : 56.70% ; Lung-Ciliated cells : 56.59% ; |
|
West Nile virus |
Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; |
|
Coxsackievirus A9 | ||
Human parechovirus 1 |
Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; |
|
Human mastadenovirus C | ||
Human betaherpesvirus 5 |
Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; Liver-Liver sinusoidal endothelial cells : 85.27% ; Liver-Cholangiocytes : 79.49% ; Lung-ATII : 73.89% ; Lung-Ciliated cells : 65.11% ; Liver-Hepatocytes : 56.17% ; Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; |
|
Human alphaherpesvirus 1 | ||
Human gammaherpesvirus 8 |
Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; |
|
Foot-and-mouth disease virus |
Lung-Ciliated cells : 92.90% ; Liver-B cells : 88.68% ; Liver-Endothelial cells : 85.05% ; Liver-Liver sinusoidal endothelial cells : 84.82% ; Spleen-Macrophages : 81.80% ; Lung-Ciliated cells : 75.66% ; Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; Lung-ATII : 55.01% ; |
|
Influenza A virus |
Heart-Epicardial cells : 87.04% ; Lung-Fibroblasts : 86.56% ; Heart-Pericytes : 84.85% ; Heart-Cardiomyocytes : 74.51% ; Spleen-Natural killer T cells : 63.84% ; Liver-Liver sinusoidal endothelial cells : 85.27% ; Liver-Cholangiocytes : 79.49% ; Lung-ATII : 73.89% ; Lung-Ciliated cells : 65.11% ; Liver-Hepatocytes : 56.17% ; Lung-Ciliated cells : 82.15% ; Liver-Cholangiocytes : 76.92% ; Heart-Epicardial cells : 74.07% ; Liver-Liver sinusoidal endothelial cells : 72.77% ; Lung-ATII : 72.44% ; |
|
Rhinovirus C |
Lung-Ciliated cells : 81.34% ; |
|
Coxsackievirus B2 |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Coxsackievirus B4 |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Coxsackievirus B6 |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Human mastadenovirus A |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Human mastadenovirus D |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Human mastadenovirus E |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Human mastadenovirus F |
Lung-ATII : 78.15% ; Lung-Ciliated cells : 56.19% ; |
|
Ebola virus |
Spleen-Macrophages : 76.29% ; Spleen-B cells : 68.93% ; Spleen-Fibroblast cells : 63.39% ; Spleen-Monocytes : 59.13% ; Liver-Kupffer cells : 58.47% ; Spleen-Macrophages : 72.92% ; Spleen-Monocytes : 56.40% ; Spleen-B cells : 55.47% ; Lung-Mast cells : 53.97% ; Liver-Cholangiocytes : 56.41% ; |
|
Marburg marburgvirus | ||
Echovirus E1 |
Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; |
|
Echovirus E8 |
Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; |
|
Human parvovirus B19 |
Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; |
|
Human metapneumovirus |
Liver-Cholangiocytes : 74.36% ; Spleen-B cells : 71.85% ; Spleen-Macrophages : 67.36% ; Liver-Liver sinusoidal endothelial cells : 66.52% ; Spleen-Monocytes : 65.67% ; |
|
Mammalian orthoreovirus | ||
Equid alphaherpesvirus 1 | ||
Human gammaherpesvirus 4 | ||
Human rotavirus strain WA | ||
Canine parvovirus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Machupo mammarenavirus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Guanarito mammarenavirus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Mouse mammary tumor virus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Argentinian mammarenavirus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Feline panleukopenia virus |
Liver-B cells : 73.16% ; Heart-Macrophages : 57.94% ; |
|
Hepatovirus A |
Spleen-Macrophages : 72.92% ; Spleen-Monocytes : 56.40% ; Spleen-B cells : 55.47% ; Lung-Mast cells : 53.97% ; |
|
Lassa mammarenavirus | ||
Human mastadenovirus B | ||
Latino mammarenavirus |
Lung-ATII : 68.29% ; Heart-Epicardial cells : 62.96% ; Liver-Liver sinusoidal endothelial cells : 60.71% ; Liver-Cholangiocytes : 58.97% ; Lung-Ciliated cells : 56.80% ; |
|
Oliveros mammarenavirus |
Lung-ATII : 68.29% ; Heart-Epicardial cells : 62.96% ; Liver-Liver sinusoidal endothelial cells : 60.71% ; Liver-Cholangiocytes : 58.97% ; Lung-Ciliated cells : 56.80% ; |
|
Lymphocytic choriomeningitis mammarenavirus |
Lung-ATII : 68.29% ; Heart-Epicardial cells : 62.96% ; Liver-Liver sinusoidal endothelial cells : 60.71% ; Liver-Cholangiocytes : 58.97% ; Lung-Ciliated cells : 56.80% ; |
|
Coxsackievirus A10 |
Lung-ATII : 66.47% ; |
|
Feline calicivirus |
Liver-Cholangiocytes : 64.10% ; Liver-Liver sinusoidal endothelial cells : 56.70% ; Lung-Ciliated cells : 56.59% ; |
|
Polytropic murine leukemia virus |
Liver-B cells : 55.26% ; |
|
Xenotropic murine leukemia virus |
Liver-B cells : 55.26% ; |
|
Gibbon ape leukemia virus |
Heart-Cardiomyocytes : 54.92% ; |
|
Amphotropic murine leukemia virus |
Heart-Cardiomyocytes : 54.92% ; |
|
Feline leukemia virus strain B/lambda-B1 |
Heart-Cardiomyocytes : 54.92% ; |
|
Human papillomavirus type 16 |
Lung-ATII : 54.53% ; |
|
Varicella Zoster Virus |
Liver-Liver sinusoidal endothelial cells : 54.02% ; |
|
Human alphaherpesvirus 3 |
Liver-Liver sinusoidal endothelial cells : 54.02% ; |